THE MED13L FOUNDATION INC

EIN: 822469441 501(c)(3) Medical Research

BARRINGTON, NJ

Total Revenue
$608,940
Total Expenses
$201,203
Total Assets
$739,788
Net Assets
$739,788
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2017
Legal Domicile
NJ
Principal Officer
KATHLEEN BARRY BOYCHUCK
Phone
8565345470
Tax Period
2023-01-01 to 2023-12-31

THE MED13L FOUNDATION INC, founded in 2017, is a small nonprofit in the Medical Research sector that reported $609K in total revenue in fiscal year 2023. Revenue surged 88% from the prior year, signaling strong growth momentum. The organization ran a surplus of $408K, a strong 67% operating margin.

Mission

MED13L PROVIDES SUPPORT FOR RESEARCH, ADVANCEMENT AND RAISING AWARENESS OF THE RARE GENETIC DISEASE, MED13L. THE OBJECTIVES OF MED13L IS TO RAISE AWARENESS IN THE LOCAL, NATIONAL AND INTERNATIONAL COMMUNITY ABOUT THE RARE GENETIC DISEASE, MED13L AND TO PROVIDE FUNDING FOR RESEARCH, DEVELOPMENT AND ADVANCEMENT INTO FIGHTING THIS DISEASE. THE ULTIMATE GOAL IS TO FIND OUT MORE ABOUT WHAT CAUSES MED13L AND FIND A CURE. IN OUR ENDEAVOR TO REACH THAT GOAL, MED13L STRIVES TO CREATE A SUPPORT SYSTEM FOR FAMILIES IMPACTED BY MED13L ALL THE WHILE PROVIDING FUNDING OPPORTUNITIES TO HEALTHCARE PROFESSIONALS AND RESEARCHERS WHO ARE HELPING TO FIND A CURE TO THIS RARE GENETIC DISEASE.

Program Service Accomplishments

Program 1
Expenses: $163,258

COORDINATE AND COLLABORATE WITH THE GLOBAL SCIENTIFIC COMMUNITY TO UNDERSTAND THE FUNCTION OF THE MED13L GENE IN ORDER TO DEVELOP EFFECTIVE TREATMENTS AND A CURE FOR MED13L SYNDROME. INCREASE MEDICAL...

Read more

COORDINATE AND COLLABORATE WITH THE GLOBAL SCIENTIFIC COMMUNITY TO UNDERSTAND THE FUNCTION OF THE MED13L GENE IN ORDER TO DEVELOP EFFECTIVE TREATMENTS AND A CURE FOR MED13L SYNDROME. INCREASE MEDICAL COMMUNITY AND PUBLIC AWARENESS OF THE COMPLEXITY AND POTENTIAL SEVERITY OF MED13L SYNDROME. PROVIDE EDUCATIONAL AND EMOTIONAL SUPPORT FOR THOSE AFFECTED BY MED13L SYNDROME. RAISE MONEY TO FUND OUR GOALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $602,092
Program Service Revenue $0
Investment Income $15,732
Other Revenue $-8,884
TOTAL REVENUE $608,940

Expense Breakdown

Grants Paid $163,258
Salaries & Benefits $0
Fundraising Expenses $2,181
Program Expenses $163,258
Other Expenses $37,945
TOTAL EXPENSES $201,203

Year-over-Year Comparison

2023 2022 Change
Revenue $608,940 $323,934 +0.9%
Expenses $201,203 $41,607 +3.8%
Net Income $407,737 $282,327 +0.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
N/A
Independent Members
N/A
Employees
N/A
Volunteers
10

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$0
Total Directors
6
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
NICK SEAVER PRESIDENT 5.00
Officer Director
$0 $0 $0
KELLY SEXTON VICE PRESIDENT 5.00
Officer Director
$0 $0 $0
KATHLEEN BARRY BOYCHUCK TREASURER 10.00
Officer Director
$0 $0 $0
KIM SOKORAI TRUSTEE 5.00
Director
$0 $0 $0
VANESSA DIAS TRUSTEE 10.00
Director
$0 $0 $0
JENNIFER ROBERTSON SECRETARY 10.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $608,940 $201,203 $739,788 $407,737
2022 $323,934 $41,607 $332,051 $282,327
Explore More Nonprofits
Top 100 Nonprofits in New Jersey Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare THE MED13L FOUNDATION INC with other nonprofits in New Jersey and across the country.